Literature DB >> 10329423

Binding affinity and reactivity of lecithin cholesterol acyltransferase with native lipoproteins.

A B Kosek1, D Durbin, A Jonas.   

Abstract

The first step in the reaction of lecithin cholesterol acyltransferase (LCAT) with lipoproteins is the interfacial binding of the enzyme to the lipid surfaces. In this study the equilibrium dissociation constants (Kds) for the interaction of pure human plasma LCAT with LDL, HDL2, HDL3, and a reconstituted discoidal HDL (rHDL) were determined by the activity-inhibition method. In addition, enzyme kinetics were measured with each of the lipoprotein substrates. Based on phospholipid concentrations, the Kd values (0.9 x 10(-5) to 4.6 x 10(-5) M) increased in the order rHDL = HDL3 </= HDL2 < LDL while the relative reactivities (app Vmax/app Km) with LCAT were 100, 16, 1, 6%, respectively, for the different lipoproteins. These quantitative measures were used to predict the distribution of LCAT in plasma and to explain cholesterol esterification when HDL are absent or ineffective as substrates. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10329423     DOI: 10.1006/bbrc.1999.0690

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  9 in total

1.  A thumbwheel mechanism for APOA1 activation of LCAT activity in HDL.

Authors:  Allison L Cooke; Jamie Morris; John T Melchior; Scott E Street; W Gray Jerome; Rong Huang; Andrew B Herr; Loren E Smith; Jere P Segrest; Alan T Remaley; Amy S Shah; Thomas B Thompson; W Sean Davidson
Journal:  J Lipid Res       Date:  2018-05-17       Impact factor: 5.922

Review 2.  Lecithin:cholesterol acyltransferase: old friend or foe in atherosclerosis?

Authors:  Sandra Kunnen; Miranda Van Eck
Journal:  J Lipid Res       Date:  2012-05-07       Impact factor: 5.922

3.  Efficacy of oral rosuvastatin intervention on HDL and its associated proteins in men with type 2 diabetes mellitus.

Authors:  Sriram Naresh; Aparna R Bitla; P V L N Srinivasa Rao; Alok Sachan; Yadagiri Lakshmi Amancharla
Journal:  Endocrine       Date:  2020-09-07       Impact factor: 3.633

4.  Metabolomic Pattern Predicts Incident Coronary Heart Disease.

Authors:  Zhe Wang; Cong Zhu; Vijay Nambi; Alanna C Morrison; Aaron R Folsom; Christie M Ballantyne; Eric Boerwinkle; Bing Yu
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-05-16       Impact factor: 8.311

5.  Mechanism and Physiologic Significance of the Suppression of Cholesterol Esterification in Human Interstitial Fluid.

Authors:  Norman E Miller; Waldemar L Olszewski; Irina P Miller; Mahmud N Nanjee
Journal:  Front Pharmacol       Date:  2016-07-15       Impact factor: 5.810

6.  Interaction of lecithin:cholesterol acyltransferase with lipid surfaces and apolipoprotein A-I-derived peptides.

Authors:  Marco G Casteleijn; Petteri Parkkila; Tapani Viitala; Artturi Koivuniemi
Journal:  J Lipid Res       Date:  2018-02-08       Impact factor: 5.922

7.  Obesity Affects HDL Metabolism, Composition and Subclass Distribution.

Authors:  Julia T Stadler; Sonja Lackner; Sabrina Mörkl; Athina Trakaki; Hubert Scharnagl; Andrea Borenich; Willibald Wonisch; Harald Mangge; Sieglinde Zelzer; Nathalie Meier-Allard; Sandra J Holasek; Gunther Marsche
Journal:  Biomedicines       Date:  2021-02-27

8.  Structural analysis of lecithin:cholesterol acyltransferase bound to high density lipoprotein particles.

Authors:  Kelly A Manthei; Dhabaleswar Patra; Christopher J Wilson; Maria V Fawaz; Lolita Piersimoni; Jenny Capua Shenkar; Wenmin Yuan; Philip C Andrews; John R Engen; Anna Schwendeman; Melanie D Ohi; John J G Tesmer
Journal:  Commun Biol       Date:  2020-01-15

9.  Comparing Levels of Metabolic Predictors of Coronary Heart Disease between Healthy Lean and Overweight Females.

Authors:  Rasha Abu-El-Ruz; Manar E Abdel-Rahman; Stephen L Atkin; Mohamed A Elrayess
Journal:  Metabolites       Date:  2021-03-15
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.